DENTSPLY International (XRAY) : Vigilant Capital Management has sold out all of its stake in DENTSPLY International during the most recent quarter, according to the disclosure filed by the company on Oct 14, 2016 with the SEC. The investment management company has sold out 56 shares of DENTSPLY International which is valued at $3,287.
Other Hedge Funds, Including , Msi Financial Services Inc reduced its stake in XRAY by selling 11 shares or 0.15% in the most recent quarter. The Hedge Fund company now holds 7,473 shares of XRAY which is valued at $432,089. DENTSPLY International makes up approx 0.02% of Msi Financial Services Inc’s portfolio.Patten Patten Inctn reduced its stake in XRAY by selling 1,876 shares or 2.37% in the most recent quarter. The Hedge Fund company now holds 77,415 shares of XRAY which is valued at $4,481,554. DENTSPLY International makes up approx 0.59% of Patten Patten Inctn’s portfolio.British Columbia Investment Management Corp reduced its stake in XRAY by selling 25,004 shares or 13.04% in the most recent quarter. The Hedge Fund company now holds 166,742 shares of XRAY which is valued at $9,652,694. DENTSPLY International makes up approx 0.10% of British Columbia Investment Management Corp’s portfolio.Bath Savings Trust Co reduced its stake in XRAY by selling 2,018 shares or 6.42% in the most recent quarter. The Hedge Fund company now holds 29,431 shares of XRAY which is valued at $1,734,663. DENTSPLY International makes up approx 0.55% of Bath Savings Trust Co’s portfolio.
DENTSPLY International opened for trading at $58.21 and hit $58.9 on the upside on Friday, eventually ending the session at $58.7, with a gain of 1.52% or 0.88 points. The heightened volatility saw the trading volume jump to 21,10,450 shares. Company has a market cap of $13,678 M.
On the company’s financial health, DENTSPLY International reported $0.76 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Aug 5, 2016. Analyst had a consensus of $0.70. The company had revenue of $1022.00 million for the quarter, compared to analysts expectations of $1028.82 million. The company’s revenue was up 46.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 EPS.
Many Wall Street Analysts have commented on DENTSPLY International. DENTSPLY International was Initiated by JP Morgan to “Neutral” on Sep 22, 2016. DENTSPLY International was Downgraded by Barrington Research to ” Mkt Perform” on Aug 8, 2016.
DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.